<?xml version="1.0" encoding="UTF-8"?>
<ref id="B18">
 <label>18.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Ishiyama</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gallagher</surname>
    <given-names>PE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Averill</surname>
    <given-names>DB</given-names>
   </name>, 
   <name name-style="western">
    <surname>Tallant</surname>
    <given-names>EA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Brosnihan</surname>
    <given-names>KB</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ferrario</surname>
    <given-names>CM</given-names>
   </name>
  </person-group>
  <article-title>Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors</article-title>. 
  <source>Hypertension</source>
  <volume>43</volume>: 
  <fpage>970</fpage>â€“
  <lpage>976</lpage>, 
  <year>2004</year>. doi:
  <pub-id pub-id-type="doi">10.1161/01.HYP.0000124667.34652.1a</pub-id>. 
  <?supplied-pmid 15007027?>
  <pub-id pub-id-type="pmid">15007027</pub-id>
 </mixed-citation>
</ref>
